Montana holds final close on €800m hard-cap
Secondaries investor Montana Capital Partners has held a final close for its fourth secondaries fund on its €800m hard-cap.
More on Funds
Gemba Private Equity heads for EUR 25m close for debut fund
Spanish GP is looking to attract further LPs interested in the local mid-cap space
Synthesis Capital holds USD 300m final close for debut fund
Costa Yiannoulis and David Welch spoke to Unquote about the food technology and alternative protein VC's strategy
ICG heads for secondaries fund close, new strategy launches
GP plans to launch specialised life sciences and US PE strategies depending on market conditions
Raise heads for second close for debut impact VC fund
French sponsor seeks to attract state-backed LPs for new strategy targeting ESG-focused startups
Latest News
FSN Capital acquires Epista Life Sciences
The GP said it will pursue a buy-and-build strategy in the life science IT services sector
Advent Life Sciences hires three partners
Dominic Schmidt is based in the UK, while Satish Jindal and Katrine Bosley join in the US
Five Arrows kicks off Laf Santé sale
Five Arrows has owned a majority stake in the France-based low-cost pharmacy chain since 2016
Hg’s MEDIFOX sale launch draws large-cap sponsor interest
Hg acquired the software platform for care providers in 2018 from ECM Equity Capital Management